Concordia Healthcare Corp. T.CXR.R

RBC New Target Price - $64 USD

[adamchess]

Including taking into account FX headwinds UK sterling/USD. CXR sp should be moving up rapidly.

[Craigbad]

Td reduced price target to $45us based on limited visibility on pipeline and lackluster legacy performance. Should be interesting to see how the next few days play out. 

[adamchess]

RBC Capial knows the company better than TD. 1st Qtr 2016 will be clean slate with nice profit. GLTA longs.

[Health123]

Adamchess, Royal Bank Capital holds a large portion of Concordia's credit facility so their targets are expected to be on the higher end.  You should do your own DD and phone Douglas Meihm and actually ask him how many of RBC Funds hold CXR/CXRX shares His number is 416-842-7823.

[adamchess]

Thanks for your suggestion Health123, but I don't really need any more DD. I have lots of confidence in Concordia management and Great West Life recently added over 600,000 shares in last quarter 2015. That tells me alot. They know healthcare business.

[Craigbad]

I like the company, but don't like the shareprice trend. I'm not going to argue over who is better between td and rbc, but i expect rbc is biased based on them being heavily involved in the financings so i would take them with a grain of salt.

[digitel]

This post has been removed in accordance with Community Policy

[adamchess]

Concordia's acquisition of AMCo can hardly be considered a roll-up. You related to nutjob?

[Pj1958]

They were right with their price targets from the IPO of $7ish to over $100..so why can't they be right from $30ish to $65+.... And the fact that it's gone down from $100+ doesn't mean they are wrong long term... Short term is all noise as the fundamentals have not changed for CXR. External noise has reduced the multiples to 10 times, which in time will show the shorts that TD, RBC and

[adamchess]

Regardless of whether you think TD or RBC valuations are more credible, I still think Great West Life investment in Concordia of over one million shares speaks volumes.